Russian news: articles, reviews about medicine in the Russian Federation :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

News

249
Regulatory News

New FDA-approved medication for hemophilia offers dosing every 2...

Fitusiran, a groundbreaking treatment for hemophilia A and B is approved by the FDA, offering a less frequent dosing schedule of once every 2 mon...

263
Regulatory News

FDA greenlights dupilumab for adolescents and adults with chronic...

Dupilumab has received FDA approval for chronic spontaneous urticaria in patients aged 12 years and older, expanding its use to over 300,000 U.S....

531
Regulatory News

Fresh from the FDA: First-ever non-opioid for acute pain is now O...

Suzetrigine is a crucial non-opioid alternative for managing acute pain, helping to reduce reliance on opioids while ensuring effective patient r...

977
Regulatory News

Pioneering antidiabetic leads as first FDA-approved therapy for o...

Tirzepatide improves sleep quality, promotes weight loss, and overall health in overweight people with obstructive sleep apnea.

1345
Regulatory News

Russia’s N protein-based vaccine emerges as strong contender in g...

N protein-based COVID-19 vaccine shows 85.2% efficacy and a strong safety profile, offering a crucial alternative for patients struggling with tr...

1590
Regulatory News

Updated non-mRNA COVID vaccine receives FDA approval for enhanced...

The updated non-mRNA COVID-19 vaccine offers targeted protection against Omicron variants for individuals 12+ with enhanced safety and efficacy.

1497
Новости Здравоохранения

FDA OKs flu shot with the advantage of self-administration like n...

Approval of self-administered flu vaccine paves the way for greater accessibility and flexibility in seasonal flu prevention, offering families a...

1586
Новости Здравоохранения

Exclusive automated insulin dosing device is now FDA-approved for...

Automated insulin dosing now extends to type 2 diabetes, streamlining daily management and enhancing glycemic control.

1280
Новости Здравоохранения

Dr. Reddy’s secures Guinness Record with massive mosaic promoting...

Colossal mosaic for 'Glycemic Happiness' reflects a commitment to a holistic approach in diabetes management that values psychological we...

1923
Новости Здравоохранения

One-of-a-kind non-injection nasal spray is now FDA-sanctioned for...

Epinephrine nasal spray for anaphylaxis offers a needle-free treatment option, reducing delays and overcoming injection fear.

1148
Regulatory News

First gene therapy for metastatic synovial sarcoma earns FDA's OK...

Afamitresgene autoleucel intravenous infusion represents a pivotal advance in treating metastatic malignant synovioma, which is crucial for patie...

2156
Новости Здравоохранения

Takeda and Dr. Reddy’s join forces to launch Vonoprazan in India

Dr. Reddy’s has partnered with Takeda to launch Vonoprazan (VONO™), a novel acid blocker enhancing its GI treatment offerings in Indi...

Try: